SPMS
Showing 1 - 25 of 172
Sepsis, Acute Respiratory Distress Syndrome Trial in Tianjin (electroacupuncture treatment, sham electroacupuncture treatment)
Not yet recruiting
- Sepsis
- Acute Respiratory Distress Syndrome
- electroacupuncture treatment
- sham electroacupuncture treatment
-
Tianjin, Tianjin, ChinaTianjin Nankai Hospital
Aug 22, 2023
Mayzent Onboarding of Secondary Progressive Multiple Sclerosis
Completed
- Secondary Progressive Multiple Sclerosis
-
Camperdown, New South Wales, Australia
- +1 more
Apr 19, 2023
Secondary Progressive Multiple Sclerosis (SPMS) Trial in Tel Aviv (SCM-010)
Not yet recruiting
- Secondary Progressive Multiple Sclerosis (SPMS)
- SCM-010
-
Tel Aviv, IsraelTel Aviv Medical Center
Oct 26, 2022
Multiple Sclerosis, Secondary Progressive Trial in Calgary (Hydroxychloroquine Pill, Indapamide Pill)
Recruiting
- Multiple Sclerosis, Secondary Progressive
- Hydroxychloroquine Pill
- Indapamide Pill
-
Calgary, Alberta, CanadaFoothills Medical Centre
May 16, 2022
Obesity Adult Onset Trial in Chapel Hill (SPM Active)
Completed
- Obesity Adult Onset
- SPM Active
-
Chapel Hill, North CarolinaUNC Chapel Hill Family Medicine Center
Jun 14, 2022
Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City
Recruiting
- Secondary Progressive Multiple Sclerosis
- +2 more
- Ferumoxytol infusion
- +2 more
-
Salt Lake City, UtahUniversity of Utah Health Imaging and Neurosciences Center
Jun 22, 2022
Multiple Sclerosis Trial in Latham (Cladribine Tablets)
Recruiting
- Multiple Sclerosis
- Cladribine Tablets
-
Latham, New YorkMultiple Sclerosis Center of Northeastern New York, P.C.
Jan 12, 2022
Microglial Activation inMS Patient Cohort at Risk of Progression
Active, not recruiting
- Multiple Sclerosis
-
Turku, Finland Proper, FinlandTurku PET Centre
May 31, 2022
Progressive Multiple Sclerosis Trial in Thessaloniki (Early Harvest Extra Virgin Olive Oil)
Completed
- Progressive Multiple Sclerosis
- Early Harvest Extra Virgin Olive Oil
-
Thessaloniki, Macedonia, GreeceA' Department of Neurology,Aristotle University of Thessaloniki
Jul 4, 2021
Mayzent on SPMS Patients in a Long-term Non-interventional Study
Recruiting
- Secondary Progressive Multiple Sclerosis With Inflammatory Disease Activity
- Siponimod
-
Baden, Aargau, Switzerland
- +8 more
May 16, 2022
Imaging Interplay Between Axonal Damage and Repair in Multiple
Recruiting
- Multiple Sclerosis (MS)
- +3 more
- MRI
- +2 more
-
Basel, SwitzerlandUniversity Hospital Basel, Department of Neurology
Dec 15, 2021
Secondary Progressive Multiple Sclerosis (SPMS) Trial in United Kingdom (Simvastatin, Placebo)
Active, not recruiting
- Secondary Progressive Multiple Sclerosis (SPMS)
- Simvastatin
- Placebo
-
Belfast, United Kingdom
- +23 more
Jul 4, 2022
Secondary Progressive Multiple Sclerosis Trial in Nottingham (Acceptance Based Telephone Support (ABS+UC))
Completed
- Secondary Progressive Multiple Sclerosis
- Acceptance Based Telephone Support (ABS+UC)
-
Nottingham, Nottinghamshire, United KingdomQueens Medical Centre, Nottingham
Sep 24, 2020
Secondary Progress Multiple Sclerosis, Multiple Sclerosis Trial in San Diego (NeuroVax, IFA Placebo)
Recruiting
- Secondary Progress Multiple Sclerosis
- Multiple Sclerosis
- NeuroVax
- IFA Placebo
-
San Diego, CaliforniaCRO
Mar 9, 2020
Multiple Sclerosis Trial in San Diego (NeuroVax, IFA Incomplete Freund's Adjuvant)
Unknown status
- Multiple Sclerosis
- NeuroVax
- IFA Incomplete Freund's Adjuvant
-
San Diego, CaliforniaCRO
Mar 9, 2020
results Surveillance for Mayzent in SPMS Patients
Recruiting
- Secondary Progressive Multiple Sclerosis (SPMS)
-
Anjo, Aichi, Japan
- +210 more
Dec 22, 2022
Multiple Sclerosis, Secondary Progressive Trial in Calgary (Domperidone)
Completed
- Multiple Sclerosis, Secondary Progressive
-
Calgary, Alberta, CanadaCalgary MS Clinic at Foothills Medical Centre
Feb 20, 2020
Lipid Mediators in Multiple Sclerosis
Completed
- Multiple Sclerosis
- Samples
-
Pozzilli, Isernia, ItalyIRCCS Neuromed
Nov 22, 2022
Post-COVID Condition Trial in Zaragoza (Active nutrititional supplement, Placebo nutrititional supplement)
Active, not recruiting
- Post-COVID Condition
- Active nutrititional supplement
- Placebo nutrititional supplement
-
Zaragoza, SpainIIS Aragón
Sep 27, 2023
Silent Progression Activity Monitoring - SPAM Study
Not yet recruiting
- Multiple Sclerosis
- NO INTERVENTION
-
Nice, FranceCHU de Nice
Dec 5, 2022
MSRV-Env Burden in Patients With Multiple Sclerosis Disease
Completed
- Multiple Sclerosis (MS)
- +4 more
- No study treatments administered - blood draws only
-
Bron cedex, France
- +3 more
Oct 19, 2020
Multiple Sclerosis Trial in France (DMT withdrawal, DMT continuation)
Recruiting
- Multiple Sclerosis
- DMT withdrawal
- DMT continuation
-
Angers, France
- +22 more
Mar 25, 2022
Arthritis, Rheumatoid Trial in Rancagua (Placebo, Omega-3, Aerobic exercise)
Active, not recruiting
- Arthritis, Rheumatoid
- Placebo
- +2 more
-
Rancagua, Libertador Bernardo O'Higgins, ChileUniversidad de O'Higgins
Jul 11, 2023
Measuring Active Microglia in Progressive Multiple Sclerosis
Completed
- Secondary Progressive Multiple Sclerosis
- [C11]PK-1195 PET scan
-
New York, New YorkWeill Cornell Medical College
Jan 14, 2022
Exercise Trial in New York (Graded-Intensity Treadmill Exercise Protocol)
Not yet recruiting
- Exercise
- Graded-Intensity Treadmill Exercise Protocol
-
New York, New YorkTisch Hospital
Jun 20, 2023